. . . . . . . . . "\"Paricalcitol injection is contraindicated in patients with: Hypercalcemia [see Warnings and Precautions ( 5.1 Vitamin D toxicity [see Warnings and Precautions ( 5.1 Known hypersensitivity to paricalcitol or any of the inactive ingredients in paricalcitol injection. Hypersensitivity adverse reactions have been reported [e.g., angioedema (including laryngeal edema) and urticaria] [see Adverse Reactions ( 6.2 Hypercalcemia ( 4 Vitamin D toxicity ( 4 Known hypersensitivity to paricalcitol or any inactive ingredient ( 4\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "Vgd+qkEXSdxvtYnbFf5PmtqjKh/GKgRJuCwMN15kqKJElcZ9sk1eF0ZGJ9m27N4TUh3+YwaN7nMPk3f/CCPaGy1YdnAFqaPapaABOzyOUkZr8TKhSN7k+6YRevL8lyKt55USHzHvxig02KD4RlVuSIrJJdS5MB0gRVUHTo9A7Zo=" . . "2021-08-23T19:03:50.432+02:00"^^ . . . . .